All terms in PATO

Label Id Description
positive regulation of cellular component biogenesis GO_0044089 [Any process that activates or increases the frequency, rate or extent of cellular component biogenesis, a process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a cellular component.]
positive regulation of extracellular matrix organization GO_1903055 [Any process that activates or increases the frequency, rate or extent of extracellular matrix organization.]
extraembryonic membrane development GO_1903867 [The process whose specific outcome is the progression of an extraembryonic membrane over time, from its formation to the mature structure.]
neuromuscular junction of myotube GO_0098523 [A neuromuscular junction in which the target muscle cell is a myotube.]
skeletal muscle fiber differentiation GO_0098528 [The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle fiber cell. Skeletal muscle fiber differentiation starts with myoblast fusion and the appearance of specific cell markers (this is the cell development step). Then individual skeletal muscle fibers fuse to form bigger myotubes and start to contract.]
skeletal muscle cell differentiation GO_0035914 [The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.]
vesicle localization GO_0051648 [Any process in which a vesicle or vesicles are transported to, and/or maintained in, a specific location.]
elastic fiber assembly GO_0048251 [Assembly of the extracellular matrix fibers that enables the matrix to recoil after transient stretching.]
extracellular matrix assembly GO_0085029 [The aggregation, arrangement and bonding together of the extracellular matrix.]
sulfur oxide CHEBI_48154
inorganic oxide CHEBI_24836
regulation of cardiac chamber formation GO_1901210 [Any process that modulates the frequency, rate or extent of cardiac chamber formation.]
negative regulation of cardiac chamber formation GO_1901211 [Any process that stops, prevents or reduces the frequency, rate or extent of cardiac chamber formation.]
positive regulation of cardiac chamber formation GO_1901212 [Any process that activates or increases the frequency, rate or extent of cardiac chamber formation.]
regulation of heart morphogenesis GO_2000826 [Any process that modulates the frequency, rate or extent of heart morphogenesis.]
nucleobase-containing molecular entity CHEBI_61120 [Any compound that has a nucleobase as a part.]
nitrogen molecular entity CHEBI_51143
heteroarene CHEBI_33833 [A heterocyclic compound formally derived from an arene by replacement of one or more methine (-C=) and/or vinylene (-CH=CH-) groups by trivalent or divalent heteroatoms, respectively, in such a way as to maintain the continuous pi-electron system characteristic of aromatic systems and a number of out-of-plane pi-electrons corresponding to the Hueckel rule (4n+2).]
norepinephrine secretion GO_0048243 [The regulated release of norepinephrine by a cell. Norepinephrine is a catecholamine and it acts as a hormone and as a neurotransmitter of most of the sympathetic nervous system.]
norepinephrine transport GO_0015874 [The directed movement of norepinephrine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Norepinephrine (3,4-dihydroxyphenyl-2-aminoethanol) is a hormone secreted by the adrenal medulla and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts of the CNS. It is also the biosynthetic precursor of epinephrine.]